Shakevia Johnson

459 total citations
15 papers, 372 citations indexed

About

Shakevia Johnson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Shakevia Johnson has authored 15 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Genetics. Recurrent topics in Shakevia Johnson's work include Kruppel-like factors research (5 papers), Genetic Syndromes and Imprinting (4 papers) and interferon and immune responses (2 papers). Shakevia Johnson is often cited by papers focused on Kruppel-like factors research (5 papers), Genetic Syndromes and Imprinting (4 papers) and interferon and immune responses (2 papers). Shakevia Johnson collaborates with scholars based in United States, Canada and Israel. Shakevia Johnson's co-authors include Xiao‐Ming Ou, Craig A. Stockmeier, Deyin Lu, Paul R. Albert, Donald B. Sittman, Jeffrey H. Meyer, Junming Wang, Moussa B. H. Youdim, Grażyna Rajkowska and Mark C. Austin and has published in prestigious journals such as Journal of Biological Chemistry, Neuropsychopharmacology and Neuropharmacology.

In The Last Decade

Shakevia Johnson

15 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shakevia Johnson United States	11	107	101	99	73	67	15	372
Michael Lewis United States	11	147 1.4×	180 1.8×	61 0.6×	69 0.9×	78 1.2×	18	425
Tatsunori Tanaka Japan	11	104 1.0×	162 1.6×	92 0.9×	64 0.9×	36 0.5×	18	366
Francesca Marchisella Italy	10	145 1.4×	159 1.6×	73 0.7×	82 1.1×	42 0.6×	13	412
Elif Tunc‐Ozcan United States	10	109 1.0×	96 1.0×	80 0.8×	67 0.9×	14 0.2×	17	384
Tzuri Lifschytz Israel	15	136 1.3×	165 1.6×	74 0.7×	83 1.1×	19 0.3×	35	496
Avia Merenlender‐Wagner Israel	7	124 1.2×	109 1.1×	47 0.5×	25 0.3×	29 0.4×	8	404
Lionel Breuillaud Canada	8	207 1.9×	116 1.1×	61 0.6×	49 0.7×	24 0.4×	13	430
Miyeon Choi South Korea	10	118 1.1×	139 1.4×	118 1.2×	50 0.7×	14 0.2×	16	379
Yun‐Fang Jia United States	13	163 1.5×	168 1.7×	54 0.5×	27 0.4×	24 0.4×	21	490
Rosamaria Orlando Italy	13	229 2.1×	238 2.4×	87 0.9×	67 0.9×	22 0.3×	23	556

Countries citing papers authored by Shakevia Johnson

Since Specialization

Citations

This map shows the geographic impact of Shakevia Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shakevia Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shakevia Johnson more than expected).

Fields of papers citing papers by Shakevia Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shakevia Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shakevia Johnson. The network helps show where Shakevia Johnson may publish in the future.

Co-authorship network of co-authors of Shakevia Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Shakevia Johnson. A scholar is included among the top collaborators of Shakevia Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shakevia Johnson. Shakevia Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Johnson, Shakevia & Peter Martin. (2017). Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. The American Journal of Drug and Alcohol Abuse. 44(3). 310–316. 10 indexed citations

Zhang, Xiao, Shakevia Johnson, Sharonda Harris, et al.. (2016). Binge ethanol exposure increases the Krüppel-like factor 11-monoamine oxidase (MAO) pathway in rats: Examining the use of MAO inhibitors to prevent ethanol-induced brain injury. Neuropharmacology. 105. 329–340. 12 indexed citations

Johnson, Shakevia, Xiao Zhang, Baoying Zheng, et al.. (2016). Up‐Regulation of PKR Signaling Pathway by Ethanol Displays an Age of Onset‐Dependent Relationship. Alcoholism Clinical and Experimental Research. 40(11). 2320–2328. 4 indexed citations

Zhang, Xiao, Shakevia Johnson, Sharonda Harris, et al.. (2015). Chronic Social Stress and Ethanol Increase Expression of KLF11, a Cell Death Mediator, in Rat Brain. Neurotoxicity Research. 28(1). 18–31. 9 indexed citations

Johnson, Shakevia, Syed A. Hussain, Gang Chen, et al.. (2015). The IFNγ-PKR Pathway in the Prefrontal Cortex Reactions to Chronic Excessive Alcohol Use. Alcoholism Clinical and Experimental Research. 39(3). 476–484. 11 indexed citations

Harris, Sharonda, Shakevia Johnson, Jeffrey H. Meyer, et al.. (2014). Evidence Revealing Deregulation of The KLF11-Mao A Pathway in Association with Chronic Stress and Depressive Disorders. Neuropsychopharmacology. 40(6). 1373–1382. 31 indexed citations

Johnson, Shakevia, Craig A. Stockmeier, Jia Luo, et al.. (2013). The Expression of KLF11 (TIEG2), a Monoamine Oxidase B Transcriptional Activator in the Prefrontal Cortex of Human Alcohol Dependence. Alcoholism Clinical and Experimental Research. 38(1). 144–151. 15 indexed citations

Grunewald, Matthew, Shakevia Johnson, Deyin Lu, et al.. (2012). Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression. Journal of Biological Chemistry. 287(29). 24195–24206. 84 indexed citations

Johnson, Shakevia, Craig A. Stockmeier, Jeffrey H. Meyer, et al.. (2011). The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive Disorder. Neuropsychopharmacology. 36(10). 2139–2148. 67 indexed citations

10.

Johnson, Shakevia, Deyin Lu, Moussa B. H. Youdim, et al.. (2010). The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis. Frontiers in Neuroscience. 4. 180–180. 26 indexed citations

11.

Ou, Xiao‐Ming, Deyin Lu, Shakevia Johnson, et al.. (2010). Ethanol Increases TIEG2–MAO B Cell Death Cascade in the Prefrontal Cortex of Ethanol-Preferring Rats. Neurotoxicity Research. 19(4). 511–518. 16 indexed citations

12.

Johnson, Shakevia, et al.. (2009). Comparative Neuroprotective Effects of Rasagiline and Aminoindan with Selegiline on Dexamethasone-Induced Brain Cell Apoptosis. Neurotoxicity Research. 15(3). 284–290. 45 indexed citations

13.

Lu, Deyin, et al.. (2008). The Neuroprotective Effect of Antidepressant Drug via Inhibition of TIEG2-MAO B Mediated Cell Death.. PubMed. 2(5). 289–295. 19 indexed citations

14.

Johnson, Shakevia, et al.. (2007). The effects of antidepressant drug on ethanol-induced cell death.. PubMed. 1(2). 130–5. 10 indexed citations

15.

Wagner, G.C., et al.. (1993). Effects of monoaminergic agonists on alcohol-induced increases in mouse aggression.. PubMed. 11(11). 185–191. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact